STOCK TITAN

DYNATRONICS CORP - DYNT STOCK NEWS

Welcome to our dedicated page for DYNATRONICS news (Ticker: DYNT), a resource for investors and traders seeking the latest updates and insights on DYNATRONICS stock.

Dynatronics Corp (NASDAQ: DYNT) is a prominent United States-based company renowned for its innovative medical devices and restorative products targeted towards achieving optimal health. Established over 31 years ago, Dynatronics has built a robust reputation for competitive pricing, exemplary customer service, and unmatched clinical support. The company designs, manufactures, and distributes advanced-technology medical devices, therapeutic tables, rehabilitation equipment, and a wide array of rehabilitation and therapy products and supplies.

Dynatronics’ product portfolio includes electrotherapy, therapeutic ultrasound, phototherapy, customized athletic training treatment tables, institutional cabinetry, and exercise products. These products are marketed to a diverse range of healthcare professionals such as physical therapists, chiropractors, athletic trainers, and sports medicine practitioners. The company’s commitment to quality is reflected in its reputable brands including Bird & Cronin®, Solaris™, Hausmann®, Physician's Choice®, and PROTEAM™, among others.

With over 60 sales representatives and 150 active distributors located nationwide, Dynatronics ensures immediate service and extensive field support, from equipment setup to in-service training. Their experienced and knowledgeable sales force is one of the most respected in the industry.

In recent developments, Dynatronics has made significant strides to optimize its cost structure and strengthen its balance sheet. The company recently entered into a new Loan and Security Agreement with Gibraltar Business Capital, enhancing its operational and financial flexibility. Additionally, Brian Baker has assumed the role of Chief Executive Officer, bringing a wealth of experience and a customer-focused approach to the leadership team.

The company has shown resilience and adaptability amidst economic challenges, continuously working on business optimization strategies. The financial guidance for fiscal year 2024 shows a net sales target of $34 million to $37 million, with a strategic focus on cost reduction and margin expansion.

Dynatronics is also focusing on launching new products, with plans for a limited launch in the third quarter and a full launch in the fourth quarter of fiscal year 2024. These new product lines are expected to complement their existing offerings and contribute to the company's revenue growth.

For more information about Dynatronics Corp and its latest updates, visit www.dynatronics.com.

Rhea-AI Summary

Dynatronics Corporation (NASDAQ:DYNT) announced it will release its financial results for Q1 FY2023 on November 10, 2022, before market open. A conference call will follow at 8:00 AM ET, featuring prepared remarks and a Q&A session with analysts. Participants can dial 888-506-0062 (U.S.) or 973-528-0011 (international) to join, using passcode 844024. An audio replay will be available post-call. The company specializes in medical devices for physical therapy and rehabilitation, marketing products through various established brands.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.65%
Tags
conferences earnings
-
Rhea-AI Summary

Dynatronics Corporation (NASDAQ: DYNT) reported financial results for Q4 FY '22, achieving net sales of $11.2 million, a 14% increase year-over-year, alongside a gross profit margin expansion to 23.4%. Despite a net loss of $1.6 million, the company forecasts FY '23 net sales of $45-$48 million, indicating a 5% growth. The CEO highlighted positive market reception to their new business model and anticipated improvements in cash flow as inventory is sold down. However, ongoing inflation, supply chain challenges, and pandemic impacts pose risks.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.56%
Tags
-
Rhea-AI Summary

Dynatronics Corporation (NASDAQ:DYNT) announced it will release its financial results for the fourth quarter and fiscal year ended June 30, 2022, on September 22, 2022, before market opens. Following the results, management will hold a conference call at 8:00 AM ET to discuss the performance, featuring a presentation and a Q&A session. Interested participants can access the call via phone or through the company’s Investor Relations website. The call is expected to provide insights into the company's recent financial metrics and future outlook.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.06%
Tags
conferences earnings
Rhea-AI Summary

Dynatronics Corporation (NASDAQ:DYNT) announced a senior leadership reorganization aimed at boosting sales growth and profitability. CEO John Krier will also serve as Chief Financial Officer, taking on responsibilities previously held by Norm Roegner, who is departing the company. Mike Withers, with extensive IT experience, is appointed as the new Chief Information Officer, filling a vacancy since 2020. These strategic changes are intended to streamline operations and align IT systems with business goals, enhancing revenue growth for the company.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.02%
Tags
management
-
Rhea-AI Summary

Dynatronics Corporation (NASDAQ:DYNT) reported its Q3 FY '22 results, highlighting a net sales of $10.3 million and a gross profit margin increase to 22.4%. Despite a net loss of $1.5 million, the company anticipates a 16% sales growth for Q4, projecting total FY '22 sales between $44 million and $45 million, approximately a 20% increase from the previous year. The firm continues to face challenges due to COVID-19 but remains focused on market share expansion and product innovations, targeting gross margins above 40% over time.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.77%
Tags
-
Rhea-AI Summary

Dynatronics Corporation (NASDAQ:DYNT) announces the release of its financial results for the fiscal third quarter ended March 31, 2022, set for May 12, 2022, before market opening. Following the announcement, a conference call will occur at 10:00 AM ET, featuring management remarks, a slide presentation, and a Q&A session with analysts. Participants can join via a dedicated phone line or through a provided webcast link. The event aims to provide insights into the company's performance and strategic outlook for investors.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.52%
Tags
Rhea-AI Summary

EAGAN, MN / ACCESSWIRE / March 24, 2022 / Dynatronics Corporation (NASDAQ:DYNT) announced its participation in Maxim Group's 2022 Virtual Growth Conference. The management's on-demand webcast for investors will be available on March 28, 2022, on the company's Investor Relations website. This conference, hosted by M-Vest, runs from March 28-30, 2022, from 9:00 a.m. to 5:00 p.m. EDT. Dynatronics specializes in manufacturing a range of medical devices for physical therapy, rehabilitation, and athletic training, marketing products under well-known brands.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.05%
Tags
conferences
-
Rhea-AI Summary

Dynatronics Corporation (NASDAQ:DYNT) announced its participation in two upcoming investor conferences: the Roth Capital Conference on March 14, 2022, and the Maxim Group Virtual Growth Conference on March 28-29, 2022. CEO John Krier will provide updates and engage in one-on-one meetings at these events. A virtual on-demand presentation and a live fireside chat will be available for investors during the Roth event, with archived access on the company's investor webpage. Dynatronics focuses on high-quality restorative products for physical therapy and rehabilitation.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.68%
Tags
conferences
-
Rhea-AI Summary

Dynatronics Corporation (NASDAQ:DYNT) reported Q2 FY '22 financial results, achieving total net sales of $10.5 million but incurring a net loss of $1.4 million. The company maintains confidence in its outlook, expecting net sales for FY '22 to range between $40 million and $45 million, up 15% from previous benchmarks. COVID-19 continues to pose challenges, including increased costs and supply chain issues. The focus remains on business transformation, new product launches, and enhancing operational efficiency to drive sustainable growth.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.58%
Tags
Rhea-AI Summary

Dynatronics Corporation (NASDAQ:DYNT) will release its fiscal second quarter results for the period ended December 31, 2021, on February 10, 2022, before market opening. A conference call and webcast will follow at 10:00 AM ET that same day, including management's remarks, a slide presentation, and a Q&A session. Access details include dialing 888-506-0062 for U.S./Canada participants or 973-528-0011 for international callers. The live webcast will be available on the company's Investor Relations website, with an archive for future viewing.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.99%
Tags

FAQ

What is the current stock price of DYNATRONICS (DYNT)?

The current stock price of DYNATRONICS (DYNT) is $0.1325 as of December 24, 2024.

What is the market cap of DYNATRONICS (DYNT)?

The market cap of DYNATRONICS (DYNT) is approximately 1.0M.

What does Dynatronics Corp specialize in?

Dynatronics Corp specializes in designing, manufacturing, and distributing advanced-technology medical devices, therapeutic and medical treatment tables, and rehabilitation equipment.

Who are the primary customers of Dynatronics?

Dynatronics markets its products to physical therapists, chiropractors, athletic trainers, sports medicine practitioners, and other medical professionals and institutions.

What recent financial steps has Dynatronics taken?

Dynatronics entered into a new Loan and Security Agreement with Gibraltar Business Capital to enhance operational and financial flexibility.

What are some of Dynatronics' well-known brands?

Some of Dynatronics’ well-known industry brands include Bird & Cronin®, Solaris™, Hausmann®, Physician's Choice®, and PROTEAM™.

What are the company's recent achievements?

Recent achievements include the optimization of the company’s cost structure, strengthening its balance sheet, and the appointment of Brian Baker as CEO.

What are Dynatronics' financial goals for fiscal year 2024?

The financial goals for fiscal year 2024 include net sales of $34 million to $37 million, focusing on cost reduction and margin expansion.

How does Dynatronics support its customers?

Dynatronics supports customers through a knowledgeable sales force, competitive pricing, excellent customer service, and field support from equipment setup to in-service training.

What new product launches are expected from Dynatronics?

Dynatronics plans a limited launch of new products in the third quarter and a full launch in the fourth quarter of fiscal year 2024, aiming to complement their existing products and drive revenue growth.

How long has Dynatronics been in business?

Dynatronics has been in business for over 31 years, establishing a solid reputation in the industry.

Where can I find more information about Dynatronics?

More information about Dynatronics can be found on their official website at www.dynatronics.com.

DYNATRONICS CORP

Nasdaq:DYNT

DYNT Rankings

DYNT Stock Data

1.01M
4.11M
43.29%
0.3%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States of America
SALT LAKE CITY